Vault-13

HighVista Strategies LLC

BOSTON, MA · CIK 1335325 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2012 · limited liability company

As an employer

US visa salary filings

Job titleFilingsMedianRange
Associate Accounting And Performance ReportingBoston, MA 2 $100,000
Quantitative AnalystBoston, MA 1 $130,000
Investment AnalystBoston, MA 1 $100,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: HighVista Strategies LLC..

$438.6m reported value +21.1% vs Q1 2026
147positions
28.2%in top 10
29 new 50 added 66 reduced 38 sold out vs Q1 2026

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INVESCO DB COMMDY INDX TRCK UNIT DBC DBC 1,057,238 $28.2m6.43% 6.43% UnchangedShares held: Q3 2025 1.4m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m
2 ABIVAX SA SPONSORED ADS ABVX ABVX 113,031 $15.1m3.43% 3.43% ReducedShares held: Q3 2025 184.5k, Q4 2025 72.2k, Q1 2026 113.3k, Q2 2026 113.0k -223 -223 -0.2%
3 REVOLUTION MEDICINES INC COM RVMD RVMD 66,983 $12.5m2.86% 2.86% ReducedShares held: Q3 2025 175.4k, Q4 2025 120.2k, Q1 2026 69.3k, Q2 2026 67.0k -2.3k -2,326 -3.4%
4 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 242,884 $11.4m2.60% 2.60% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 185.9k, Q2 2026 242.9k +57.0k +57,028 30.7%
5 IMMUNOVANT INC COM IMVT IMVT 277,873 $10.7m2.44% 2.44% AddedShares held: Q3 2025 253.1k, Q4 2025 221.9k, Q1 2026 225.1k, Q2 2026 277.9k +52.7k +52,734 23.4%
6 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 30,210 $10.1m2.31% 2.31% AddedShares held: Q3 2025 95.0k, Q4 2025 25.8k, Q1 2026 26.3k, Q2 2026 30.2k +3.9k +3,887 14.8%
7 RELAY THERAPEUTICS INC COM RLAY RLAY 506,235 $9.5m2.16% 2.16% AddedShares held: Q3 2025 240.5k, Q4 2025 545.1k, Q1 2026 421.9k, Q2 2026 506.2k +84.4k +84,354 20.0%
8 ALKERMES PLC SHS ALKS ALKS 179,256 $9.4m2.14% 2.14% AddedShares held: Q3 2025 44.1k, Q4 2025 26.4k, Q1 2026 73.2k, Q2 2026 179.3k +106.1k +106,067 144.9%
9 VAXCYTE INC COM PCVX PCVX 149,739 $8.7m1.98% 1.98% AddedShares held: Q3 2025 86.8k, Q4 2025 114.0k, Q1 2026 124.6k, Q2 2026 149.7k +25.1k +25,092 20.1%
10 TANGO THERAPEUTICS INC COM TNGX TNGX 260,070 $8.1m1.85% 1.85% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 104.2k, Q2 2026 260.1k +155.9k +155,877 149.6%
11 LIQUIDIA CORPORATION COM NEW LQDA LQDA 97,896 $7.8m1.78% 1.78% ReducedShares held: Q3 2025 176.5k, Q4 2025 156.0k, Q1 2026 99.7k, Q2 2026 97.9k -1.8k -1,848 -1.9%
12 COGENT BIOSCIENCES INC COM COGT COGT 188,780 $7.3m1.67% 1.67% ReducedShares held: Q3 2025 462.4k, Q4 2025 336.7k, Q1 2026 197.1k, Q2 2026 188.8k -8.3k -8,271 -4.2%
13 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 130,784 $7.0m1.60% 1.60% AddedShares held: Q3 2025 236.2k, Q4 2025 193.0k, Q1 2026 123.9k, Q2 2026 130.8k +6.9k +6,875 5.5%
14 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 137,866 $7.0m1.60% 1.60% AddedShares held: Q3 2025 259.1k, Q4 2025 82.5k, Q1 2026 73.1k, Q2 2026 137.9k +64.8k +64,764 88.6%
15 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 386,080 $6.9m1.58% 1.58% AddedShares held: Q3 2025 0, Q4 2025 238.8k, Q1 2026 352.1k, Q2 2026 386.1k +34.0k +33,995 9.7%
16 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 77,807 $6.9m1.57% 1.57% ReducedShares held: Q3 2025 215.7k, Q4 2025 188.2k, Q1 2026 146.3k, Q2 2026 77.8k -68.5k -68,457 -46.8%
17 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 211,511 $6.9m1.57% 1.57% AddedShares held: Q3 2025 0, Q4 2025 140.1k, Q1 2026 173.6k, Q2 2026 211.5k +37.9k +37,916 21.8%
18 CYTOKINETICS INC COM NEW CYTK CYTK 78,003 $6.6m1.52% 1.52% AddedShares held: Q3 2025 132.9k, Q4 2025 114.6k, Q1 2026 58.6k, Q2 2026 78.0k +19.4k +19,360 33.0%
19 C4 THERAPEUTICS INC COM STK CCCC CCCC 1,348,136 $6.3m1.44% 1.44% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.3m
20 TYRA BIOSCIENCES INC COM TYRA TYRA 184,774 $5.9m1.35% 1.35% AddedShares held: Q3 2025 65.8k, Q4 2025 35.1k, Q1 2026 131.3k, Q2 2026 184.8k +53.5k +53,470 40.7%
21 ALUMIS INC COM ALMS ALMS 199,968 $5.6m1.28% 1.28% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 112.9k, Q2 2026 200.0k +87.0k +87,039 77.1%
22 PHARVARIS N V COM PHVS PHVS 160,494 $5.5m1.27% 1.27% AddedShares held: Q3 2025 0, Q4 2025 162.4k, Q1 2026 97.9k, Q2 2026 160.5k +62.6k +62,628 64.0%
23 TARSUS PHARMACEUTICALS INC COM TARS TARS 87,060 $5.5m1.25% 1.25% AddedShares held: Q3 2025 24.9k, Q4 2025 53.6k, Q1 2026 52.5k, Q2 2026 87.1k +34.6k +34,596 65.9%
24 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 371,120 $5.3m1.20% 1.20% AddedShares held: Q3 2025 0, Q4 2025 498.9k, Q1 2026 364.4k, Q2 2026 371.1k +6.8k +6,760 1.9%
25 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 51,125 $5.0m1.14% 1.14% AddedShares held: Q3 2025 54.2k, Q4 2025 48.5k, Q1 2026 35.6k, Q2 2026 51.1k +15.5k +15,538 43.7%
26 NURIX THERAPEUTICS INC COM NRIX NRIX 203,739 $4.9m1.13% 1.13% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 226.5k, Q2 2026 203.7k -22.8k -22,807 -10.1%
27 AXSOME THERAPEUTICS INC COM AXSM AXSM 20,183 $4.9m1.13% 1.13% ReducedShares held: Q3 2025 9.3k, Q4 2025 11.1k, Q1 2026 20.4k, Q2 2026 20.2k -254 -254 -1.2%
28 TRAVERE THERAPEUTICS INC COM TVTX TVTX 86,233 $4.9m1.12% 1.12% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 36.3k, Q2 2026 86.2k +49.9k +49,908 137.4%
29 VERA THERAPEUTICS INC CL A VERA VERA 105,907 $4.5m1.04% 1.04% AddedShares held: Q3 2025 91.2k, Q4 2025 0, Q1 2026 69.2k, Q2 2026 105.9k +36.7k +36,666 53.0%
30 NVIDIA CORPORATION COM NVDA NVDA 21,792 $4.4m0.99% 0.99% ReducedShares held: Q3 2025 13.4k, Q4 2025 14.2k, Q1 2026 22.4k, Q2 2026 21.8k -628 -628 -2.8%
31 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 158,770 $4.3m0.97% 0.97% ReducedShares held: Q3 2025 241.9k, Q4 2025 240.5k, Q1 2026 213.2k, Q2 2026 158.8k -54.4k -54,442 -25.5%
32 PALISADE BIO INC COM PALI PALI 2,030,927 $4.2m0.97% 0.97% AddedShares held: Q3 2025 0, Q4 2025 1.3m, Q1 2026 2.0m, Q2 2026 2.0m +11.6k +11,601 0.6%
33 ARGENX SE SPONSORED ADR ARGX ARGX 4,561 $4.2m0.96% 0.96% ReducedShares held: Q3 2025 4.1k, Q4 2025 3.6k, Q1 2026 4.9k, Q2 2026 4.6k -357 -357 -7.3%
34 MAZE THERAPEUTICS INC COM MAZE MAZE 136,572 $4.1m0.93% 0.93% AddedShares held: Q3 2025 0, Q4 2025 170.4k, Q1 2026 99.8k, Q2 2026 136.6k +36.7k +36,722 36.8%
35 OCULAR THERAPEUTIX INC COM OCUL OCUL 408,534 $4.0m0.91% 0.91% ReducedShares held: Q3 2025 106.6k, Q4 2025 344.1k, Q1 2026 441.6k, Q2 2026 408.5k -33.0k -33,039 -7.5%
36 ORUKA THERAPEUTICS INC COM ORKA ORKA 41,902 $4.0m0.91% 0.91% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 78.9k, Q2 2026 41.9k -37.0k -37,009 -46.9%
37 DYNE THERAPEUTICS INC COM DYN DYN 171,961 $3.8m0.87% 0.87% ReducedShares held: Q3 2025 0, Q4 2025 59.6k, Q1 2026 182.9k, Q2 2026 172.0k -11.0k -10,968 -6.0%
38 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 90,996 $3.7m0.84% 0.84% ReducedShares held: Q3 2025 208.1k, Q4 2025 171.1k, Q1 2026 91.9k, Q2 2026 91.0k -935 -935 -1.0%
39 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 187,946 $3.7m0.83% 0.83% ReducedShares held: Q3 2025 19.1k, Q4 2025 0, Q1 2026 194.0k, Q2 2026 187.9k -6.0k -6,009 -3.1%
40 INSMED INC COM PAR $.01 INSM INSM 31,256 $3.3m0.76% 0.76% AddedShares held: Q3 2025 49.9k, Q4 2025 39.4k, Q1 2026 24.3k, Q2 2026 31.3k +6.9k +6,940 28.5%
41 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 86,964 $3.2m0.74% 0.74% ReducedShares held: Q3 2025 135.3k, Q4 2025 51.8k, Q1 2026 89.4k, Q2 2026 87.0k -2.4k -2,433 -2.7%
42 AMAZON COM INC COM AMZN AMZN 13,397 $3.2m0.73% 0.73% ReducedShares held: Q3 2025 26.4k, Q4 2025 17.4k, Q1 2026 22.4k, Q2 2026 13.4k -9.0k -9,000 -40.2%
43 INVENTIVA SA ADS IVA IVA 831,442 $3.1m0.72% 0.72% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 615.7k, Q2 2026 831.4k +215.8k +215,776 35.0%
44 TALEN ENERGY CORP COM TLN TLN 8,148 $3.1m0.71% 0.71% AddedShares held: Q3 2025 5.1k, Q4 2025 3.5k, Q1 2026 3.1k, Q2 2026 8.1k +5.0k +5,030 161.3%
45 RELMADA THERAPEUTICS INC COM RLMD RLMD 445,799 $3.1m0.70% 0.70% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 445.8k
46 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 24,460 $3.0m0.68% 0.68% ReducedShares held: Q3 2025 121.7k, Q4 2025 73.5k, Q1 2026 33.9k, Q2 2026 24.5k -9.4k -9,392 -27.7%
47 ERASCA INC COM ERAS ERAS 160,328 $2.9m0.67% 0.67% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 181.1k, Q2 2026 160.3k -20.7k -20,741 -11.4%
48 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 159,885 $2.9m0.67% 0.67% AddedShares held: Q3 2025 469.3k, Q4 2025 372.5k, Q1 2026 134.2k, Q2 2026 159.9k +25.7k +25,656 19.1%
49 HEWLETT PACKARD ENTERPRISE C COM HPE HPE 59,081 $2.7m0.61% 0.61% ReducedShares held: Q3 2025 98.7k, Q4 2025 76.2k, Q1 2026 90.0k, Q2 2026 59.1k -30.9k -30,900 -34.3%
50 MINERALYS THERAPEUTICS INC COM MLYS MLYS 86,085 $2.3m0.53% 0.53% AddedShares held: Q3 2025 209.8k, Q4 2025 124.5k, Q1 2026 46.8k, Q2 2026 86.1k +39.3k +39,307 84.0%
51 GUARDANT HEALTH INC COM GH GH 15,419 $2.3m0.53% 0.53% ReducedShares held: Q3 2025 64.6k, Q4 2025 36.8k, Q1 2026 23.4k, Q2 2026 15.4k -7.9k -7,938 -34.0%
52 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 122,610 $2.3m0.52% 0.52% AddedShares held: Q3 2025 27.8k, Q4 2025 95.6k, Q1 2026 58.6k, Q2 2026 122.6k +64.0k +63,988 109.2%
53 JAMES HARDIE INDS PLC ORD SHS JHX JHX 85,198 $2.2m0.51% 0.51% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 65.6k, Q2 2026 85.2k +19.6k +19,600 29.9%
54 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 155,704 $2.2m0.51% 0.51% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 183.0k, Q2 2026 155.7k -27.3k -27,333 -14.9%
55 MASTEC INC COM MTZ MTZ 5,137 $2.1m0.49% 0.49% AddedShares held: Q3 2025 6.7k, Q4 2025 5.0k, Q1 2026 3.6k, Q2 2026 5.1k +1.5k +1,510 41.6%
56 XENON PHARMACEUTICALS INC COM XENE XENE 35,318 $2.1m0.49% 0.49% ReducedShares held: Q3 2025 82.2k, Q4 2025 0, Q1 2026 49.0k, Q2 2026 35.3k -13.7k -13,732 -28.0%
57 RBC BEARINGS INC COM RBC RBC 3,223 $2.1m0.47% 0.47% AddedShares held: Q3 2025 3.5k, Q4 2025 2.7k, Q1 2026 2.7k, Q2 2026 3.2k +560 +560 21.0%
58 VISA INC COM CL A V V 5,961 $2.0m0.47% 0.47% ReducedShares held: Q3 2025 7.9k, Q4 2025 6.3k, Q1 2026 7.1k, Q2 2026 6.0k -1.2k -1,180 -16.5%
59 ASSEMBLY BIOSCIENCES INC COM NEW ASMB ASMB 73,405 $2.0m0.46% 0.46% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 74.7k, Q2 2026 73.4k -1.3k -1,330 -1.8%
60 STOKE THERAPEUTICS INC COM STOK STOK 61,316 $2.0m0.46% 0.46% ReducedShares held: Q3 2025 0, Q4 2025 115.5k, Q1 2026 62.6k, Q2 2026 61.3k -1.3k -1,301 -2.1%
61 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 160,167 $2.0m0.46% 0.46% AddedShares held: Q3 2025 437.2k, Q4 2025 241.5k, Q1 2026 117.6k, Q2 2026 160.2k +42.6k +42,566 36.2%
62 ROCKET COS INC COM CL A RKT RKT 125,530 $2.0m0.45% 0.45% AddedShares held: Q3 2025 0, Q4 2025 97.4k, Q1 2026 92.4k, Q2 2026 125.5k +33.1k +33,100 35.8%
63 XPO INC COM XPO XPO 9,623 $2.0m0.45% 0.45% AddedShares held: Q3 2025 21.1k, Q4 2025 12.7k, Q1 2026 8.9k, Q2 2026 9.6k +700 +700 7.8%
64 WESTERN DIGITAL CORP COM WDC WDC 3,050 $1.9m0.44% 0.44% ReducedShares held: Q3 2025 14.2k, Q4 2025 0, Q1 2026 4.1k, Q2 2026 3.0k -1.1k -1,050 -25.6%
65 CORE SCIENTIFIC INC NEW COM CORZ CORZ 75,712 $1.9m0.44% 0.44% ReducedShares held: Q3 2025 75.2k, Q4 2025 63.5k, Q1 2026 103.4k, Q2 2026 75.7k -27.7k -27,700 -26.8%
66 TEXAS INSTRS INC COM TXN TXN 6,500 $1.9m0.44% 0.44% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.5k
67 KBR INC COM KBR KBR 54,206 $1.9m0.43% 0.43% AddedShares held: Q3 2025 35.5k, Q4 2025 30.0k, Q1 2026 39.4k, Q2 2026 54.2k +14.8k +14,800 37.6%
68 FLOWSERVE CORP COM FLS FLS 24,958 $1.9m0.42% 0.42% UnchangedShares held: Q3 2025 39.0k, Q4 2025 25.0k, Q1 2026 25.0k, Q2 2026 25.0k
69 ALPHABET INC CAP STK CL C GOOG GOOG 5,127 $1.8m0.41% 0.41% ReducedShares held: Q3 2025 9.8k, Q4 2025 6.3k, Q1 2026 5.5k, Q2 2026 5.1k -350 -350 -6.4%
70 SEAGATE TECHNOLOGY HLDNGS PL ORD SHS STX STX 1,870 $1.8m0.41% 0.41% ReducedShares held: Q3 2025 6.9k, Q4 2025 0, Q1 2026 2.9k, Q2 2026 1.9k -1.0k -1,030 -35.5%
71 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 14,892 $1.7m0.40% 0.40% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 15.6k, Q2 2026 14.9k -671 -671 -4.3%
72 DNOW INC COM DNOW DNOW 132,900 $1.7m0.39% 0.39% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 132.9k
73 ON SEMICONDUCTOR CORP COM ON ON 18,200 $1.7m0.39% 0.39% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 28.0k, Q2 2026 18.2k -9.8k -9,800 -35.0%
74 NUCOR CORP COM NUE NUE 7,600 $1.7m0.39% 0.39% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.6k
75 GANNETT CO INC COM TDAY TDAY 188,500 $1.6m0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 188.5k
76 BROADCOM INC COM AVGO AVGO 4,199 $1.6m0.36% 0.36% ReducedShares held: Q3 2025 10.2k, Q4 2025 5.6k, Q1 2026 5.6k, Q2 2026 4.2k -1.4k -1,400 -25.0%
77 CALUMET INC COM CLMT CLMT 44,000 $1.6m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 44.0k
78 QNITY ELECTRONICS INC COMMON STOCK Q Q 9,700 $1.6m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.7k
79 KODIAK SCIENCES INC COM KOD KOD 40,590 $1.6m0.36% 0.36% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 43.6k, Q2 2026 40.6k -3.0k -2,979 -6.8%
80 CREDO TECHNOLOGY GROUP HOLDI ORDINARY SHARES CRDO CRDO 5,800 $1.6m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.8k
81 KNIGHT-SWIFT TRANSN HLDGS IN CL A KNX KNX 20,100 $1.6m0.36% 0.36% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 22.9k, Q2 2026 20.1k -2.8k -2,800 -12.2%
82 BRINKS CO COM BCO BCO 16,414 $1.6m0.35% 0.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 16.4k
83 ASTERA LABS INC COM ALAB ALAB 3,198 $1.5m0.35% 0.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.2k
84 S&P GLOBAL INC COM SPGI SPGI 3,782 $1.5m0.35% 0.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.8k
85 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 2,852 $1.5m0.35% 0.35% AddedShares held: Q3 2025 3.5k, Q4 2025 2.8k, Q1 2026 2.6k, Q2 2026 2.9k +254 +254 9.8%
86 EQUIFAX INC COM EFX EFX 9,572 $1.5m0.35% 0.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.6k
87 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 13,657 $1.5m0.35% 0.35% ReducedShares held: Q3 2025 37.5k, Q4 2025 42.9k, Q1 2026 16.8k, Q2 2026 13.7k -3.1k -3,139 -18.7%
88 SAVARA INC COM SVRA SVRA 242,379 $1.5m0.34% 0.34% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 251.0k, Q2 2026 242.4k -8.6k -8,620 -3.4%
89 DOMINOS PIZZA INC COM DPZ DPZ 4,991 $1.5m0.34% 0.34% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.0k
90 BELITE BIO INC SPONSORED ADS BLTE BLTE 9,554 $1.5m0.34% 0.34% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 8.0k, Q2 2026 9.6k +1.5k +1,521 18.9%
91 MICRON TECHNOLOGY INC COM MU MU 1,260 $1.5m0.33% 0.33% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.8k, Q2 2026 1.3k -2.5k -2,540 -66.8%
92 CIENA CORP COM NEW CIEN CIEN 2,925 $1.4m0.33% 0.33% ReducedShares held: Q3 2025 0, Q4 2025 5.2k, Q1 2026 5.3k, Q2 2026 2.9k -2.4k -2,360 -44.6%
93 CELCUITY INC COM CELC CELC 13,472 $1.4m0.32% 0.32% AddedShares held: Q3 2025 13.7k, Q4 2025 16.5k, Q1 2026 13.1k, Q2 2026 13.5k +367 +367 2.8%
94 QXO INC COM NEW QXO QXO 81,420 $1.4m0.32% 0.32% AddedShares held: Q3 2025 90.2k, Q4 2025 58.7k, Q1 2026 26.3k, Q2 2026 81.4k +55.1k +55,100 209.3%
95 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 43,185 $1.4m0.31% 0.31% ReducedShares held: Q3 2025 0, Q4 2025 33.0k, Q1 2026 58.7k, Q2 2026 43.2k -15.5k -15,512 -26.4%
96 CG ONCOLOGY INC COM CGON CGON 18,867 $1.3m0.31% 0.31% ReducedShares held: Q3 2025 26.0k, Q4 2025 29.3k, Q1 2026 19.9k, Q2 2026 18.9k -1.0k -1,047 -5.3%
97 US FOODS HLDG CORP COM USFD USFD 13,000 $1.3m0.30% 0.30% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.0k
98 TRANSDIGM GROUP INC COM TDG TDG 985 $1.3m0.30% 0.30% ReducedShares held: Q3 2025 0, Q4 2025 2.2k, Q1 2026 1.1k, Q2 2026 985 -160 -160 -14.0%
99 LUMENTUM HLDGS INC COM LITE LITE 1,517 $1.3m0.30% 0.30% ReducedShares held: Q3 2025 12.9k, Q4 2025 4.3k, Q1 2026 3.1k, Q2 2026 1.5k -1.6k -1,600 -51.3%
100 FIRSTENERGY CORP COM FE FE 26,100 $1.2m0.28% 0.28% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 26.1k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
TERNS PHARMACEUTICALS INC 114,307 $6.0m114.3k shares
NUVALENT INC 56,602 $5.8m56.6k shares
SOLENO THERAPEUTICS INC SLNO SLNO 165,227 $5.5m165.2k shares
APOGEE THERAPEUTICS INC 35,761 $3.0m35.8k shares
JAZZ PHARMACEUTICALS PLC JAZZ JAZZ 10,838 $2.0m10.8k shares
NCR ATLEOS CORPORATION NATL NATL 40,100 $1.7m40.1k shares
CLEAN HARBORS INC CLH CLH 5,543 $1.6m5.5k shares
SALESFORCE INC CRM CRM 8,313 $1.6m8.3k shares
XOMA ROYALTY CORPORATION XOMA XOMA 46,814 $1.5m46.8k shares
AVANTOR INC AVTR AVTR 186,500 $1.5m186.5k shares
ASCENDIS PHARMA A/S 5,781 $1.3m5.8k shares
INTUIT INTU INTU 3,003 $1.3m3.0k shares
BOOKING HOLDINGS INC BKNG BKNG 7,075 $1.2m7.1k shares
KILROY RLTY CORP KRC KRC 41,997 $1.2m42.0k shares
EQT CORP EQT EQT 18,290 $1.2m18.3k shares
PETROLEO BRASILEIRO SA PETRO PBR.A PBR.A 59,400 $1.1m59.4k shares
WORKDAY INC WDAY WDAY 8,286 $1.1m8.3k shares
PTC INC PTC PTC 7,474 $1.1m7.5k shares
GE VERNOVA INC GEV GEV 1,218 $1.1m1.2k shares
ARGAN INC AGX AGX 1,896 $1.0m1.9k shares
AMRIZE LTD AMRZ AMRZ 17,068 $956.1k17.1k shares
REDDIT INC RDDT RDDT 6,900 $929.1k6.9k shares
3M CO MMM MMM 6,150 $893.2k6.2k shares
UNION PAC CORP UNP UNP 3,658 $887.5k3.7k shares
COUPANG INC CPNG CPNG 46,036 $869.2k46.0k shares